(Total Views: 61)
Posted On: 03/29/2019 12:00:03 PM
Post# of 35809
Intellipharmaceutics International Inc. (IPCIF: OTCQB) | U.S. FDA Acknowledges Receipt of Intellipharmaceutics' Resubmission of Oxycodone ER New Drug Application, Deems it a Complete Response, and Designates August 28, 2019 as Goal Date for Review
(0)
(0)
